glezisim 10 mg/40 mg tablety
glenmark pharmaceuticals s.r.o., Česká republika - simvastatín a ezetimib - 31 - hypolipidaemica
glezisim 10 mg/10 mg tablety
glenmark pharmaceuticals s.r.o., Česká republika - simvastatín a ezetimib - 31 - hypolipidaemica
onureg
bristol-myers squibb pharma eeig - azacitidín - leukémia, myeloidná, akútna - antineoplastické činidlá - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
ebglyss
almirall, s.a. - lebrikizumab - dermatitída, atopická - ostatné dermatologické prípravky - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.